Status:
COMPLETED
Breast Cancer AI Imaging Study
Lead Sponsor:
University of Central Florida
Conditions:
Breast Cancer
Breast Cancer Screening
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to develop a social health platform called MammoChat (https://MammoChat.com) that allows patients to share their real-world patient data to a trusted network for development of clinica...
Detailed Description
With over 40,000,000 mammograms run annually in the US, there are psychological consequences of breast cancer imaging that are well documented among patients such as stress and anxiety from largely fa...
Eligibility Criteria
Inclusion
- Adults, ages 18 and older
- Had a radiographic breast cancer imaging test, either for screening or diagnosis of breast cancer, with either positive or negative results performed in a US institution.
- Have an email account with access to a reliable internet connection or smartphone
Exclusion
- Minors , ages under 18
- Prisoners. Given the repository design, prisoners are unlikely to participate and provide a consent
- Adults who are unable to provide consent.
Key Trial Info
Start Date :
September 5 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2025
Estimated Enrollment :
199 Patients enrolled
Trial Details
Trial ID
NCT06604078
Start Date
September 5 2024
End Date
September 1 2025
Last Update
September 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Central Florida
Orlando, Florida, United States, 32827